The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking

International Journal of Pharmacy Practice

Volumn 7, Issue 2, 1999, Pages 107-112

  Sinclair, Hazel K ^a   Silcock, Jonathan ^b   Bond, Christine M ^a   Lennox, A Scott ^a   Winfield, Arthur J ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PHARMACY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; UNITED KINGDOM;

EID: 0032807522     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.1999.tb00957.x     Document Type: Article

References (19)

1. Secretary of State for Health. The health of the nation. London: HM Stationery Office, 1992.
2. Secretary of State for Scotland. Scotland's health: a challenge to us all. Edinburgh: HM Stationery Office, 1992.
3. Secretary of State for Health. Our healthier nation. London: Stationery Office, 1998.
4. Maguire T. Smoking cessation, nicotine replacement and community pharmacy. Pharm J 1997;258:239-40.
5. Mason P. Action on smoking - can pharmacists make a difference? Pharm J Ibid 1996;256;263-5.
6. Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counselling smokers to quit. JAMA 1989;261:75-9.
7. Imperial Cancer Research Fund general practice research group. Randomised trial of nicotine patches in general practice: results at one year. BMJ 1994;308:1476-7.
8. Russell MAH, Stapleton JA, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, et al. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ Ibid 1993;306:1308-12.
9. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-42.
10. Kennedy EJ. Social and behavioural aspects of pharmacy. In: Winfield AJ, Richards RME, editors. Pharmaceutical Practice, 2nd ed. Edinburgh: Churchill Livingston, 1998.
11. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 1983;51:390-5.
12. Sinclair H, Bond CM, Lennox AS, Silcock J, Winfield A. An evaluation of a training workshop for community pharmacists and pharmacy assistants based on the Stage of Change Model of smoking cessation. Health Educ J 1997;56:296-312.
13. Sinclair H, Bond CM, Lennox AS, Silcock J, Winfield A. Knowledge of and attitudes to smoking cessation: the effect of stage of change training for community pharmacy staff. Health Bulletin 1998;56:526-39.
14. Sinclair H, Bond CM, Lennox AS, Silcock J, Winfield A, Donnan P. Training pharmacists and pharmacy assistants in the stage of change model of smoking cessation: a randomised controlled trial in Scotland. Tobacco Control 1998;7:253-61.
15. Cauley SD. The time price of medical care. Rev Econ Statistics 1987;69:59-66.
16. Office for National Statistics. New Earnings Survey 1995. Part A: Table 1.5. London: HM Stationery Office, 1995.
17. Oster G, Huse DM, Delea TE, Colditz GA. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA 1986;256:1315-8.
18. McGhan WF, Dix-Smith M. Pharmacoeconomic analysis of smoking cessation interventions. Am J Health-Systems Pharmacy 1996;53:45-52.
19. Buck D. The cost-effectiveness of smoking cessation interventions: what do we know? Int J Health Educ 1997;35:44-52.